Delivery Order SPE2DB22D1106-SPE2DB24FDZU2
Award Date 2/12/24
Potential Completion Date 2/13/24
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,020.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,476,985 units of the pharmaceutical product Ketorolac 60 mg/2 ml vial. The contract has a completion date of January 31, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and the parent company is Cencora, Inc., which does business as...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,741,257 units of the pharmaceutical product Ketorolac 60 mg/2 ml vial 2 ml. The contract has a completion date of February 23, 2024 and a potential value of $1,236.08. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide KETOROLAC 60 MG/2 ML VIAL 2ML. The contract has a potential value of $1,931.50 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a Firm Fixed Price Delivery Order to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, for the supply of Ketorolac 30mg/ml in 25-count packages. The order has a potential value of $1,406.10 and a completion date of February 14, 2024. This award is part of an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $3,380.97 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide KETOROLAC 60 MG/2 ML VIAL 2ML. This delivery order is part of a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to military treatment...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ketorolac 30mg/ml pharmaceutical products. The contract has a potential value of $1,406.10 and a completion date of February 14, 2024. This delivery order is issued under a larger indefinite delivery contract held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,221.97 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4563573342 KETOROLAC 30 MG/ML VIAL. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,585.69 firm fixed price delivery order is for the supply of Ketorolac 30 mg/ml vials, a specialty pharmaceutical product. The contract has an ultimate completion date of March 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ketorolac 60 mg/2 ml vial (2 ml). The contract, which does not have a set-aside designation, is a Delivery Order with a Firm Fixed Price of $1,164.06 and a completion date of June 16, 2025. The contract is funded by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen Drug Corp is the prime contractor and there are no noted subcontractors. This contract is...
- The Defense Logistics Agency awarded a $57,410 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac injectable solution. The one-day contract supports DLA's medical supply needs and calls for Amerisourcebergen to deliver 4562070934 units of ketorolac 30 mg/ml vials from its Conshohocken, Pennsylvania distribution facility. As the prime contractor, Amerisourcebergen will perform under its Corporate Office Division banner and draw upon parent company...